The Future of Assertio Holdings Looks Promising as Stockholders Overwhelmingly Approve Acquisition Transaction Introduction In a...

Despite a challenging funding environment, ArriVent Biopharma has managed to secure a whopping $155 million in its Series B funding. This...

Avadel Pharmaceuticals plc (Nasdaq: AVDL), a renowned biopharmaceutical organization dedicated to revolutionizing medicines to transform...

BioNTech has recently expanded its portfolio in the realm of cancer research and development. It has sealed a deal worth $170 million...

Everest Medicines, a trailblazer in the biopharmaceutical realm, recently declared its alliance with Shanghai Pharma subsidiary, SPH...

Introduction A revolutionary collaboration has been announced between Tubulis, a German biopharmaceutical firm, and Bristol Myers Squibb...

On April 20, 2023, Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) "Vallon", announced that during a special meeting, its stockholders have...

OpGen, Inc., a renowned precision medicine company, and its German subsidiary, Curetis GmbH, have successfully achieved all the remaining...

Polydex Pharmaceuticals Limited, a Toronto-based biotechnology company, recently announced a strategic business deal with BioSpectra Inc....